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Abstract
IMPORTANCE Changes in estradiol during aging are associated with increased dementia risk. It
remains unclear how estradiol supports cognitive health and whether risk factors, such as midlife
obesity, are exacerbated by estrogen loss.
OBJECTIVES To assess whether visceral adipose tissue (VAT) moderates the association between
age and brain network structure and to investigate whether estradiol moderates the association
between VAT and brain network structure.
DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study of data from 974 cognitively healthy
adults in Germanywho participated in theHealth Study of the Leipzig Research Centre for Civilization
Diseases, a previously described population-based cohort study. Twomoderation analyses were
performed, including VAT as the moderator variable between age and brain network structure and
estradiol as the moderator variable between VAT and brain network structure. The study was
conducted from August 1, 2011, to November 23, 2014. Analyses were conducted from August 2017
to September 2018.
EXPOSURES Serum estradiol levels from fasting blood and visceral adipose tissue volume from
T1-weightedmagnetic resonance imaging (MRI).
MAINOUTCOMESANDMEASURES Brain network covariance (individual loading on structural
network derived from T1-weightedMRI) andmemory performance (composite score from the
Consortium to Establish a Registry for Alzheimer Disease [CERAD] verbal episodic memory test on
learning [score range, 0-30], recall [score range, 0-10], and recognition [score range, 0-20]).
RESULTS Final analyses included data from 473 women (mean [SD] age, 50.10 [15.63] years) and
501 men (mean [SD] age, 51.24 [15.67] years). Visceral adipose tissue was associated with an
exacerbation of the negative association of aging with network covariance for women (interaction
term β = −0.02; 95% bias-corrected bootstrap CI, −0.03 to −0.01; P = .001) and men (interaction
term β = −0.02; 95% bias-corrected bootstrap CI, −0.03 to −0.01; P < .001). Estradiol level was
associated with a reduction in the negative association of VATwith network covariance in women
(interaction term β = 0.63; 95% bias-corrected bootstrap CI, 0.14-1.12; P = .01), with no significant
association in men. In the female midlife subgroup (age range, 35-55 years, whenmenopause
transition occurs), low estradiol levels were associated with lower memory network covariance




Question Does estradiol mitigate the
negative association of visceral fat with
structural brain networks and
cognitive health?
Findings In this cross-sectional study of
a German population-based cohort of
974 adults, higher estradiol levels were
associated with increased structural
brain network covariance and a
reduction in the negative association of
visceral fat with network covariance,
but only for women. In women, higher
estradiol levels were associated with
better structural network covariance
and cognitive performance
during midlife.
Meaning Assessing visceral adipose
tissue and hormone profiles, particularly
in women during midlife, may be
essential for promoting a healthy brain
aging trajectory.
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Abstract (continued)
CONCLUSIONS ANDRELEVANCE This study reports a novel association between VAT, estradiol,
and structural brain networks as a potential mechanism underlying cognitive decline in women.
These findings appear to highlight the need for sex-specific strategies, including VAT and hormonal
screening during midlife, to support healthy cognitive aging.
JAMA Network Open. 2019;2(6):e196126. doi:10.1001/jamanetworkopen.2019.6126
Introduction
Neuroimaging evidence suggests an association between age-related brain atrophy, cognitive
decline, and obesity.1 Emerging data linking obesity to increased cognitive impairment in old age are
concerning given that approximately 39% of the world’s adult population are overweight and 13%
are obese.2 Visceral adipose tissue (VAT) is a known risk factor for vascular andmetabolic diseases,3-5
but the results of some studies6,7 suggest that elevated VATmay also impair cognitive function.
Behaviorally, increased VAT is associated with reduced verbal memory, attenuated attention, and
lower executive function. Expanded VAT is further linked to brain atrophy, such as decreased
hippocampal volume, cortical thickness, and total brain volume.6,8 Consequently, researchers are
starting to view visceral obesity in midlife as a risk factor for dementia and depression in later life9,10
independent of type 2 diabetes and cardiovascular comorbidities, with the findings of other
studies11,12 suggesting an even stronger association in women.
Expanded VAT is associated with systemic inflammatory biomarkers, proinflammatory
cytokines,13-15 and reduced levels of adipocyte-specific proteins with anti-inflammatory properties,
for which substantial sex differences are reported.13,16 Visceral adipose tissue is also associated with
dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis andmay contribute to cortisol
regeneration17 and vulnerability to stress-induced cortisol reactivity in women.18 Moreover, if VAT
compromises brain structural integrity owing to its association with systemic inflammation and HPA
dysregulation, estradiol may have a protective role due to its anti-inflammatory properties and ability
to strengthen HPA robustness.19 This is in line with menopause transition risk models for
neuropsychiatric disorders, which suggest that ovarian hormone fluctuations induce alterations in
stress response pathways.20 Further support for the moderating role of estradiol stems from the
finding that estradiol replacement reduces metabolic syndrome symptoms in estradiol-depleted
women.21-23 Estradiol also has vasodilatory, antiapoptotic, and antioxidative effects, which could
help preservemyelin architecture.24-26 Although VAT and estradiol appear to have opposing roles in
association with healthy brain aging, it remains unclear how they interactively alter brain network
structure. This has serious implications for female cognitive decline in later life because women are
potentially more sensitive to the effects of VAT on cognition.7 Moreover, dementia in women is likely
influenced bymidlife obesity,27 a time also characterized by rapid, unstable decreases in estradiol.28
To investigate these associations in adults, we require integration of brain, abdominal, hormonal, and
cognitive data.
We addressed these issues in a novel way by integrating measures of brain network structure,
VAT, sex hormones, and cognitive function in a comprehensive data set of 974 participants (473
women) aged 19 to 79 years.We first characterized a structural brain network that shows accelerated
degeneration with aging and, when compromised, has been associated with poor memory
performance and vulnerability to unhealthy aging and disease.29,30 After validating that this network
correlated with memory performance, we explored how associations between VAT, estradiol levels,
and structural brain network covariance differ between men and women. To our knowledge, this is
the first study to examine how these factors interact to shed light on biological mechanisms
underlying cognitive decline. In a secondary analysis, we investigated how estradiol levels are
associated with network covariance andmemory performance specifically in midlife women (age
range, 35-55 years) because this is a crucial transition point whenmidlife obesity is a recognized risk
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factor for dementia27 and estradiol levels are known to fluctuate during themenopause transition.28
Based on the research summarized above linking brain network structure, VAT, estradiol levels, and
cognitive function, we hypothesized (1) that VAT would be associated with an amplification of the
negative association of age with brain network structure and cognitive health and (2) that estradiol
would be associated with a reduction in the negative association of VAT with structural network
covariance and cognitive performance in women.
Methods
Participants
Data from 1159 participants were taken from a German population-based cohort study, the Health
Study of the Leipzig Research Centre for Civilization Diseases (LIFE). Participants provided written
informed consent after all procedures were explained. The protocol and informed consent forms
were approved by the research ethics board of the University of Leipzig. Study design and
assessment information were described previously31 (eAppendix 1 in the Supplement). Excluded
from analysis were 183 individuals owing to medication intake altering the central nervous system,
immunosuppressivemedication, previous stroke or other lesions, current diagnosed cancer or cancer
treatment during the previous year, head tumors, epilepsy, multiple sclerosis, or Parkinson disease.
One individual was excluded because of failure of themacro for fat tissue segmentation and another
individual owing to missing anthropometric data needed for VAT normalization. In total, 974
participants were included in the final analyses, all of whomwere confirmed to not have dementia
during a neuropsychological assessment, including the Mini-Mental State Examination, by a trained
study physician. Dates of the original cohort study were August 1, 2011, to November 23, 2014.
Analyses were conducted from August 2017 to September 2018. This study followed the
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.32
Brain andAbdomen Imaging
Magnetic resonance imaging (MRI) data were acquired on a 3-T imaging system (Magnetom Verio;
Siemens). It was equipped with a 32-channel head array coil and body coil for the transmit-receive
coil of abdominal scans.
Abdominal Data Acquisition andAnalysis
Magnetic resonance imaging was performed using an axial T1-weighted fast spin-echo technique
with the following variables: echo time of 18milliseconds per repetition time of 520milliseconds,
echo train length of 7; slice thickness of 5 mm, 5mm between slices; scanningmatrix of 320 × 306
pixels (no partial Fourier); and field of view of 500mm ×375mm, final voxel size of 1.6 mm ×1.6 mm
×5.0mm,water saturation. Nine slices under and 10 slices above the umbilicus, diaphragm excluded,
were segmented. The abdominal fat tissue segmentation was graphically evaluated using a macro
to distinguish visceral or subcutaneous fat semiautomatically in ImageJ (https://imagej.nih.gov/ij/
download/) by 4 raters (M.H., M.R., U.S., and a nonauthor) for accuracy. The results were inspected
visually (slice by slice, identifying misclassified fat and nonfat voxels) and corrected for minor voxel
misclassifications manually in 897 participants (eAppendix 2 in the Supplement).
Brain Data Acquisition andAnalysis
We collected a 3-dimensional magnetization-prepared rapid acquisition with gradient echo
(MPRAGE) sequence using the Alzheimer Disease Neuroimaging Initiative (ADNI) standard protocol
with the following variables: inversion time of 900milliseconds, repetition time of 2300
milliseconds, echo time of 2.98milliseconds, flip angle of 9°, band width of 240 Hz per pixel, image
matrix of 256 × 240 pixels, 176 partitions, field of view of 256 × 240 × 176mm3, sagittal orientation,
1 average. Voxel size was 1 × 1 × 1 mm3, with no interpolation.33,34 We processed structural
T1-weighted data with FSL-VBM (FSL, version 5.0.9), an optimized voxel-basedmorphometry
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protocol using FMRIB Software Library (FSL) tools. All structural images were brain extracted, gray
matter segmented, and registered to the Montreal Neurological Institute (MNI) 152 standard space
using nonlinear registration. A symmetric study-specific gray matter template was built from images
of the study population. All native gray matter images were nonlinearly registered to this study-
specific template and “modulated” to correct for local expansion or contraction due to the nonlinear
component of the spatial transformation. Modulated images were smoothed with an isotropic
gaussian kernel with a sigma of 4mm (approximately 9.4-mm full width at half maximum). Before
FSL-VBM processing, volumes weremasked by the full brain–segmented volume output from
FreeSurfer (FreeSurfer, version 5.3.0) to exclude nonbrain compartments. Brain structural
information was derived from vertexwise cortical thickness, and surface area was calculated in
FreeSurfer by an automated surface reconstruction scheme.We inspected all surface reconstructions
for misplaced boundaries in FreeView (implemented in FreeSurfer) andmanually corrected 142
cases. Cortical thickness and surface areamaps were sampled from participant space to the common
FsAverage template (163 842 vertices) and smoothed with a surface full width at half maximum of
10 mm. Linked independent component analysis was then applied to measures of gray matter
volume, cortical thickness, and pial area (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLICA), decomposing the
data into 70 independent components. For each component, we calculated an individual course per
participant, further indicated as network covariance,35,36 which reflects individual loading on the
brain network.
Memory Testing
We used the 10-word verbal episodic memory test from the neuropsychological test battery of the
Consortium to Establish a Registry for Alzheimer Disease (CERAD),37 from which we calculated a
composite score per participant according to previous studies30,38-40 (eAppendix 3 in the
Supplement). The composite score was from the CERAD verbal episodic memory test on learning
(score range, 0-30), recall (score range, 0-10), and recognition (score range, 0-20). To assess
performance independent of educational achievement, all memory performance scores used are
unstandardized education residuals.
HormoneMeasurement
Serum estradiol levels from fasting blood were assessed in a subsample of 390 participants (181
women). Estradiol level was measured by electrochemiluminescence immunoassay (ECLIA) (Cobas;
Roche), with a sensitivity of 5.01 pg/mL and representative interassay coefficients of variation of
4.4% to 9.9% for the range of 85 to 110 pg/mL and 2.7% to 5.6% for the range of 501 to 555 pg/mL
(to convert estradiol level to picomoles per liter, multiply by 3.671).
Statistical Analysis
Statistical analyses were performed using SPSS Statistics 24 (IBM) and R 3.3.2 (R Foundation).
Visceral adipose tissue values were height standardized and log-transformed. Estradiol levels were
log-transformed. We performed a linear regression with memory network covariance as the
independent variable andmemory performance as the dependent variable, controlling for age. To
investigate VAT accumulation rates, we generated regressionmodels for women andmen separately
using age as the independent variable and VAT as the dependent variable for each 1-year age bin. To
assess best fit, we compared R2 values of linear, quadratic, and polynomial fit of third degree. To
examine sex interactions in the association between VAT andmemory network covariance, we
performed amultiple linear regression with VAT as the independent variable and network covariance
as the dependent variable. To assess the association between estradiol level and this network
independent of age, we performed a linear regression with estradiol level as the independent
variable and network covariance as the dependent variable using unstandardized age residuals of
network covariance.
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Moderation analyses were conducted separately per sex with the PROCESSmacro (SAS
Institute), a modeling program using an ordinary least squares–based path analytical framework to
test for direct and indirect associations.41 We tested regression pathways in a moderation model
(first model) (PROCESS, version 3.0) (eFigure 1 in the Supplement). Variables were mean centered
before analyses. A 95% bias-corrected bootstrap CI (BBCI), excluding zero and based on 10000
bootstrap samples, was considered to be a robust result.41 In the first model, we assessed
significance and stability of the interaction of VAT and age in association with network covariance by
defining age as the independent variable, network covariance as the outcome variable, and VAT as
the moderator variable. In the secondmodel, we defined VAT as the independent variable, memory
network covariance as the outcome variable, and estradiol as themoderator variable.
Finally, we assessed a subgroup of 82 women in midlife (age range, 35-55 years, when
menopause transition occurs). In these women, we performed an estradiol-level median split and
compared themean differences in memory network covariance andmemory performance using
independent-samples t tests. All testing was 2 sided, and P < .05 was considered statistically
significant.
Results
In total, 974 participants were included in analyses (Table). The female sample (n = 473) had amean
(SD) age of 50.10 (15.63) years (age range, 20-78 years), and themale sample (n = 501) had amean
(SD) age of 51.24 (15.67) years (age range, 19-79) years.
Structural Brain Network Covariance andMemory Performance
We replicated a structural network linked tomemory performance and cognitive decline29
(Figure 1A, eAppendix 4 in the Supplement for network reproducibility analyses, and eFigure 2 in the
Supplement for other networks). The network explains 17% of total variance in the imaging data,
revealing a transmodal network of cortical and limbic gray matter regions. The network is composed
of 57% gray matter volume (explaining 20% of total gray matter volume variance), 42% cortical
thickness (explaining 29% of total cortical thickness variance), and 2% pial area (explaining 1% of
total pial area variance). Higher individual structural covariance was associated with better memory
performance (adjusted R2 = 0.21; β = 0.46; P < .001) (Figure 1B). Data indicate an expected ceiling
effect for memory performance in a healthy population.42
SexDifferences in VATVolumeAcross Age
We obtained VAT volume information by segmenting visceral from subcutaneous fat in abdominal
MRI (Figure 2A). Men and women displayed different trends in VAT accumulation. For men, a
Table. Study Population Demographic Characteristics
Variable All Women Men P Value
Age, y
No. of participants 974 473 501
.26
Mean (SD) 50.69 (15.65) 50.10 (15.63) 51.24 (15.67)
BMI
No. of participants 974 473 501
<.001
Mean (SD) 26.47 (4.62) 25.87 (5.13) 27.04 (4.00)
VAT, cm3
No. of participants 974 473 501
<.001
Mean (SD) 2188.40 (1462.27) 1569.93 (1059.40) 2772.30 (1548.57)
Estradiol, pg/mL
No. of participants 390 181 209
<.001
Mean (SD) 40.76 (73.68) 61.84 (103.89) 22.50 (9.61)
Abbreviations: BMI, bodymass index (calculated as
weight in kilograms divided by height in meters
squared); VAT, visceral adipose fat tissue.
SI conversion factor: To convert estradiol level to
picomoles per liter, multiply by 3.671.
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quadratic model revealed the best fit (adjusted R2 = 0.93; P < .001) compared with the linear model
(F1,58 = 101.56; P < .001) (Figure 2B). The quadratic function showed a concave progression with a
steady slope decrease. For women, a polynomial model of third degree showed the best fit (adjusted
R2 = 0.85; P < .001) compared with the linear model (F1,59 = 4.25; P = .02) and quadratic model
(F2,58 = 7.74; P = .007). The cubic curve progression began convex and became concave at the
inflection point of 47 years. Therefore, men in this sample had the highest VAT to age ratio at an
earlier age, and this decreased with age; in contrast, women had the highest VAT to age ratio
during midlife.
SexDifferences in VAT andMemoryNetwork Association
We observed an interaction of VAT and sex onmemory network covariance (F3 = 163.37; adjusted
R2 = 0.33; P = .02): men showed a stronger negative association between VAT and network
covariance (adjusted R2 = 0.33; β = −0.57; P < .001) than women (adjusted R2 = 0.29; β = −0.54;
Figure 1. Brain Network Covariance andMemory Performance
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Correlation between memory performance and brain network covarianceB
Brain Network Covariance, Arbitrary Units
Color bars indicate z-scored positive (red/yellow) or negative (blue/light-blue) covariations within the network.
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P < .001) (Figure 3A). We conducted amoderation analysis in both sexes (Figure 3B) and found that
overall models formen (F3,497 = 474.43; R
2 = 0.74; P < .001) andwomen (F3,469 = 322.31; R
2 = 0.67;
P < .001) were significant. The interaction of VAT and age was significant for women (interaction
term β = −0.02; t469 = 4.07; 95% BBCI, −0.03 to −0.01; P = .001) andmen (interaction term
β = −0.02; t497 = −4.83; 95% BBCI, −0.03 to −0.01; P < .001), suggesting that VAT is a moderator of
the association between age and network covariance in both sexes and is associated with an
exacerbation of the negative association of aging with memory network covariance.
SexHormones andMemoryNetwork Covariance
Linear regression analysis revealed a significant positive association between estradiol levels and
memory network covariance in women after adjustment for age (adjusted R2 = 0.07; P = .002)
(Figure 4A). In the next set of moderation analyses (Figure 4B), we again found that overall models
were significant for both men (F3,205 = 30.13; R
2 = 0.31; P < .001) and women (F3,177 = 19.60;
Figure 2. Sex Differences in the Association Between Visceral Adipose Tissue and Age





































20 60 8040 47
Correlation between visceral fat and ageB
Age, y
High Visceral FatLow Visceral Fat
Age: 48; BMI: 26 Age: 48; BMI: 26





A, Representative visceral adipose tissue
segmentations in 2 women and 2men. Participants of
the same sex, age, and body mass index (BMI;
calculated as weight in kilograms divided by height in
meters squared) can have vastly different fat
distribution profiles. B, Nonlinear correlation between
visceral adipose tissue and age in women andmen.
For women, the dashed line shows the inflection point.
JAMANetworkOpen | Neurology Association of Estradiol and Visceral Fat With Structural Brain Networks andMemory
JAMA Network Open. 2019;2(6):e196126. doi:10.1001/jamanetworkopen.2019.6126 (Reprinted) June 21, 2019 7/15
Downloaded From: https://jamanetwork.com/ by a Max Planck Institute for Cognitive and Brain Sciences User  on 07/05/2019






























Correlation between memory network covariance and VATA Moderation analysisB
VAT/Height Log, cm2
Visceral fat
Age Memory network covariance
Male
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A, The plot shows simple slopes of VAT and structural network covariance for each sex, which differ significantly. The VAT values were height standardized and log-transformed. B,
Moderation analysis of interaction of VAT and age on network covariance in both sexes.
































































































Memory performance comparison in womenD
A, The plot shows a simple slope of estradiol and structural network covariance. B,
Moderation analysis of interaction of visceral adipose tissue and estradiol on network
covariance. C and D, The inner box plot shows themedian (centers) and interquartile
range (borders), with whiskers extending 1.5 times the interquartile range. The width of
the shaded area shows the proportion of data located there. To convert estradiol level to
picograms per milliliter, divide by 3.671.
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R2 = 0.25; P < .001). However, the interaction of VAT and estradiol level was significant only for
women (interaction term β = 0.63; 95% BBCI, 0.14-1.12; t177 = 2.52; P = .01), suggesting that estradiol
is a moderator of the association between VAT and network covariance in women and is associated
with a mitigation of the negative association of VATwith memory network covariance.
Finally, in the female subgroup (age range, 35-55 years), the low estradiol and high estradiol
groups did not differ by age or VAT. However, low estradiol level was associated with lower memory
network covariance (Cohen d = 0.61; t80 = 2.76; P = .007) (Figure 4C) and worse memory
performance (Cohen d = 0.63; t76 = 2.76; P = .007) (Figure 4D).
Discussion
To our knowledge, this is the first large, population-based study to investigate associations between
structural patterns of brain aging, VAT as a metabolic risk factor for structural brain atrophy, and
estradiol levels in adults of a broad age range. Our primary finding is that, while VAT was associated
with increased risk for compromised brain network structure and cognitive impairment in both men
and women, estradiol level was associated with reducing the negative consequences of VAT in
women. Specifically, men had the highest VAT to age ratio at an earlier age; in women during midlife,
VAT was associated with accelerated cognitive aging, and estradiol may protect the female brain
against these structural patterns of atrophy, particularly during midlife. Our results have important
clinical implications for developing sex-specific strategies to support healthy cognitive aging.
To effectively preserve cognitive abilities throughout life, it is imperative to consider sex-specific
risk trajectories and identify biological mechanisms that may degrade or protect relevant brain
network integrity. Integrating MRI-based VAT in large cross-sectional neuroimaging studies on
cognitive function represents a novel approach to identify such amechanism.We specifically
included VAT as themain adiposity measure given the well-established role of VAT in conferring
metabolic and inflammatory risk.3-5,13 Assessing VAT volume byMRI rather than with more
conventional and easily accessible anthropometric proxies, such as bodymass index or waist to hip
ratio, is even more critical given the findings indicating VAT as a unique risk factor for
neurodegenerative processes.10,43-45 Our analysis revealed substantial sex differences not only in
VAT accumulation but also in the association between VAT and brain health: while both sexes showed
a negative association of VATwithmemory network covariance, this associationwas stronger inmen.
When studying a brain network implicated in cognitive decline, it is difficult to control for
changes accompanying natural aging. To disentangle the associations of biological aging from the
association of VAT with memory network covariance, we tested VAT as a moderator variable in the
association between age and thememory network. Our analysis revealed a significant interaction of
VAT and age on network covariance, suggesting that VAT is associatedwith accelerated brain aging.
Our findings thus substantially extend prior research showing an association of VATwith brain tissue
damage independent of age associations.46While those authors applied age correction in their
analysis, the study was conducted in elderly individuals (mean age, 65 years); therefore, the
possibility of age as a confounder for the sample could not be excluded.
Althoughmultiple mechanismsmay have contributed to the observed sex differences in the
association between VAT and network covariance herein, differences in ovarian hormone states
across the life span, particularly estrogen fluctuations, have been shown to influence cognitive aging
processes.47,48 Thus, we investigated the role of estradiol and identified a positive association
between estradiol and network covariance in women after age correction. Although the effect size
appears small, small associations can suggest strong support for a given phenomenon, particularly if
they have substantial cumulative consequences.49 Our findings indicate that ovarian aging goes
beyond biological age-related brain changes and adds an additional layer to this process. This is
important because of the prominent sexual dimorphism in neuropsychiatric disorder rates. A
detailed understanding of these processesmay provide critical insight into how to address the higher
rates of depression50 and dementia51,52 in women. A subsequent moderation analysis revealed a
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significant interaction of VAT and estradiol on network covariance in women, suggesting that
estradiol is a significant moderator of the VAT-brain association in women. This association could be
accounted for by several mechanisms. First, estradiol has anti-inflammatory properties, and systemic
inflammation has been shown to occur in response to estradiol depletion in women (eg, after
ovariectomy,53 natural menopause,54 or treatment with the antiestrogenic drug tamoxifen55).
Second, VAT increases HPA axis dysregulation, which could harm the brain, and estradiol strengthens
robustness of HPA activity. Third, estradiol has vasodilatory, antiapoptotic, and antioxidative effects
that could have a neuroprotective role and help preservemyelin architecture.24-26 The present study
cannot identify what themechanism is behind how VAT damages structural networks or how
estradiol provides a potential protective association. However, our study results argue for
longitudinal studies to assess changes in ovarian hormones, VAT accumulation, cognitive
performance, and structural brain networks in women during perimenopause to provide insight into
a transition period that may serve as the tipping point into neurodegenerative disease. Moreover,
given growing evidence that fluctuations in ovarian hormones and their derived neurosteroids
induce HPA axis dysregulation, thereby driving vulnerability to psychosocial stress and
neuropsychiatric disease,20 a future study could benefit from includingmarkers of HPA axis function
in conjunction with psychosocial stress evaluation.
Finally, we investigated the association of estradiol with cognitive health in women during
midlife (age range, 35-55 years) because this is when we observed an inflection point in the curve for
VAT ratios in women in our cross-sectional sample. It is also the age range when women typically
experience rapid estradiol fluctuations and significant estradiol depletion during perimenopause.28
We found less healthy patterns of memory network covariance and weaker memory performance in
womenwith lower estradiol levels compared with womenwith higher estradiol levels during the
perimenopausal age range. Because these womenwere VAT- and age-matched, our findings suggest
that associations of ovarian aging with body and brain may extend beyond changes in body
composition and brain network structure typically observed during biological aging.56,57 This could
explain why VAT had less of a negative association with network covariance in women than in men.
Limitations
It is important to acknowledge themethodological limitations of data-driven neuroimaging analysis,
particularly regarding the interpretation of structural brain covariance changes in terms of cellular
mechanisms.29,58 Specifically, structural MRI is limited to probing information on amacroscopic
scale, and extraction of morphological features of interest fromMRI remains imperfect, thus making
it difficult to disentangle the contributing cellular mechanisms. Despite these constraints,
experts29,58 still agree that thismethodological approach represents a powerful tool to obtain unique
insights into human brain organization. By combining this approach with cutting-edge abdominal
adiposity imaging and assessment of sex hormone levels—and ultimately relating thesemultimodal
measures to memory performance in a large sample—we provide a biologically relevant view of the
consequences of VAT on brain network structure and cognitive abilities. Furthermore, not all
measures herein (estradiol levels and educational achievement) were available for all enrolled
participants owing to technical reasons; therefore, some analyses reported could only be conducted
in subgroups. We also acknowledge that the CERAD verbal episodic memory test shows ceiling
associations in young healthy participants, but the observation that the identified brain network in
our sample is associated with memory performance and cognitive decline has also been
demonstrated with other cognitive tests.29 In addition, brain aging is a multifaceted process; while
we applied strict screening criteria to exclude neurodegenerative or cerebrovascular disease and
controlled for age and educational achievement, we cannot exclude that other variables could
contribute to this process. Inherent to the cross-sectional design, no causal association can be
inferred because all reported associations are correlational; therefore, future studies applying within-
subject modeling are needed.
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Conclusions
Given the dramatic increase in human life expectancy over the past century, age-related cognitive
decline is rapidly becoming one of the biggest health challenges we face.59-61 Herein, we identified
sex-specific risk trajectories of brain and cognitive aging. We provide evidence for a detrimental
association of VATwith structural brain networks important for memory and a potential protective
association of estradiol with cognitive health in women through maintaining gray matter network
integrity. These data underscore the need to consider adipose tissue and hormonal profiles during
primary care visits in midlife to support healthy brain aging and maintain cognitive abilities in later
life. Our findings highlight the perimenopausal transition as a window of opportunity to prevent
accelerated brain aging and neurodegenerative disease development in women.
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